Maaike P Smit1, Ed H G van Leer1, Gerard Noppe2, Yolanda B de Rijke3, Dieneke Kramer van Driel1, Erica L T van den Akker4. 1. Department of Paediatrics, Groene Hart Hospital, Gouda, the Netherlands. 2. Department of Paediatrics and Internal Medicine, Sophia Children's Hospital-Erasmus MC, Rotterdam, the Netherlands. 3. Department of Clinical Chemistry, Erasmus MC, Rotterdam, the Netherlands. 4. Department of Paediatrics, Sophia Children's Hospital-Erasmus MC, Rotterdam, the Netherlands.
Abstract
INTRODUCTION: Inhaled corticosteroids (ICS) can interfere with the hypothalamic-pituitary-adrenal (HPA) axis and may lead to adrenal insufficiency, resulting in a decrease of cortisol production. Cortisol levels measured in scalp hair provide a marker for long-term cortisol exposure. Data regarding hair cortisol concentration (HCC) in asthmatic children with ICS therapy are scarce. The aim of this study is to compare HCC in asthmatic children under ICS treatment with a healthy control group. METHODS: We set up a case-control study measuring the cortisol concentration in scalp hair in asthmatic children (N = 80) treated with ICS and healthy controls (N = 252) aged 4-18 years. Anthropometric characteristics and hair samples from the posterior vertex were obtained. At least 5 mg of the most proximal 3 cm of hair was used for each hair sample. HCC was analyzed by liquid chromatography-tandem mass spectrometry. RESULTS: HCC did not significantly differ between asthmatic children using ICS and healthy controls (p = 0.950) after adjustment for age, gender, height, body mass index, and socioeconomic status. No correlation was found between budesonide dosage and HCC levels (r = -0.031, p = 0.78). CONCLUSION: There was no evidence of suppression of basal cortisol production, as measured in scalp hair, in asthmatic children using ICS, compared to healthy controls. No conclusions can be drawn on the HPA-axis stress response in these children.
INTRODUCTION: Inhaled corticosteroids (ICS) can interfere with the hypothalamic-pituitary-adrenal (HPA) axis and may lead to adrenal insufficiency, resulting in a decrease of cortisol production. Cortisol levels measured in scalp hair provide a marker for long-term cortisol exposure. Data regarding hair cortisol concentration (HCC) in asthmatic children with ICS therapy are scarce. The aim of this study is to compare HCC in asthmatic children under ICS treatment with a healthy control group. METHODS: We set up a case-control study measuring the cortisol concentration in scalp hair in asthmatic children (N = 80) treated with ICS and healthy controls (N = 252) aged 4-18 years. Anthropometric characteristics and hair samples from the posterior vertex were obtained. At least 5 mg of the most proximal 3 cm of hair was used for each hair sample. HCC was analyzed by liquid chromatography-tandem mass spectrometry. RESULTS: HCC did not significantly differ between asthmatic children using ICS and healthy controls (p = 0.950) after adjustment for age, gender, height, body mass index, and socioeconomic status. No correlation was found between budesonide dosage and HCC levels (r = -0.031, p = 0.78). CONCLUSION: There was no evidence of suppression of basal cortisol production, as measured in scalp hair, in asthmatic children using ICS, compared to healthy controls. No conclusions can be drawn on the HPA-axis stress response in these children.
Authors: A M Fredriks; S van Buuren; R J Burgmeijer; J F Meulmeester; R J Beuker; E Brugman; M J Roede; S P Verloove-Vanhorick; J M Wit Journal: Pediatr Res Date: 2000-03 Impact factor: 3.756
Authors: Gerard Noppe; Elisabeth F C Van Rossum; Jan Willem Koper; Laura Manenschijn; G Jan Bruining; Yolanda B de Rijke; Erica L T van den Akker Journal: Horm Res Paediatr Date: 2014-08-09 Impact factor: 2.852
Authors: Arvid W A Kamps; Marco Molenmaker; Ramses Kemperman; Betty S van der Veen; Gianni Bocca; Nic J G M Veeger Journal: Acta Paediatr Date: 2014-05-29 Impact factor: 2.299
Authors: Dana Bailey; David Colantonio; Lianna Kyriakopoulou; Ashley H Cohen; Man Khun Chan; David Armbruster; Khosrow Adeli Journal: Clin Chem Date: 2013-05-01 Impact factor: 8.327
Authors: Hilal Ince-Askan; Erica L T van den Akker; Yolanda B de Rijke; Elisabeth F C van Rossum; Johanna M W Hazes; Radboud J E M Dolhain Journal: RMD Open Date: 2019-01-30
Authors: Marcela Lopez; Monica O Ruiz; Cynthia R Rovnaghi; Grace K-Y Tam; Jitka Hiscox; Ian H Gotlib; Donald A Barr; Victor G Carrion; Kanwaljeet J S Anand Journal: Pediatr Res Date: 2021-01-18 Impact factor: 3.756
Authors: Esmé J Baan; Erica L T van den Akker; Marjolein Engelkes; Yolanda B de Rijke; Johan C de Jongste; Miriam C J M Sturkenboom; Katia M Verhamme; Hettie M Janssens Journal: Pediatr Pulmonol Date: 2019-10-25